信息搜索
信息关键字：药
  
『查询2022年信息』  『查询2021年信息』  『查询2020年信息』  『查询2019年信息』  『查询2018年信息』  『查询2017年信息』  『查询2016年信息』
『查询2015年信息』  『查询2014年信息』  『查询2013年信息』  『查询2012年信息』  『查询2011年信息』  『查询2010年信息』  『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]

·医药行业周报：医保续谈政策缓和，持续关注中报业绩预期2023-7-10 17:11:25
·中药集采专题跟踪：中成药集采逐步扩面，集采规则相对温和2023-7-10 17:07:09
·华润双鹤：硫酸阿米卡星注射液通过仿制药质量和疗效一致性评价2023-7-10 16:57:41
·雀巢据悉正在考虑向Stallergenes出售花生过敏药2023-7-10 16:53:30
·医药生物行业周报：政策叠加新版基药利好，关注儿科中成药2023-7-10 16:50:03
·医药生物行业周报：国谈续约规则发布，创新药支付端回暖2023-7-10 15:31:54
·加多宝回应被判赔偿广药集团3.17亿元：将立即提起上诉2023-7-10 15:31:02
·医药生物行业跟踪周报：医保谈判药品续约规则更新，新规则利好创新药放量2023-7-10 13:21:00
·福安药业：子公司收到硫辛酸注射液的药品注册证书2023-7-10 11:45:22
·医药生物行业周报：医保谈判续约规则边际改善，有利创新药放量2023-7-10 11:05:20
·商贸零售行业周报：关注华东医药利拉鲁肽获批减重适应症，本周新增重点推荐水羊股份2023-7-10 10:56:48
·或因未按时履行还款义务 香雪制药被申请强制执行2023-7-10 1:14:43
·医药生物周跟踪：支付新政下，创新可乐观2023-7-9 21:22:21
·医药生物行业周报：医保续约规则更新，减缓药价降幅，创新药支付环境边际改善2023-7-9 21:18:36
·美妆行业周报：华东医药利拉鲁肽减重适应症获批，抢占减肥蓝海市场2023-7-9 21:05:14
·复星医药剧透肉毒素应用新可能 或有望错位竞争2023-7-9 20:02:01
·药明合联生物技术有限公司向港交所提交上市申请2023-7-9 18:45:58
·普利制药：注射用更昔洛韦（0.25 g）获得中国一致性评价2023-7-9 17:34:45
·伊朗谴责美国同意向乌克兰提供集束弹药2023-7-9 15:23:12
·美媒：拜登绕过法律强推援乌集束弹药遭质疑2023-7-9 15:10:40

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]